切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2021, Vol. 15 ›› Issue (02) : 121 -125. doi: 10.3877/cma.j.issn.1674-3253.2021.02.008

所属专题: 文献

临床研究

S.T.O.N.E.评分与肾结石经皮肾镜术后清石率及并发症的相关性分析
周剑芳1, 高诚1, 阳东荣1,()   
  1. 1. 215004 苏州大学附属第二医院泌尿外科
  • 收稿日期:2020-03-09 出版日期:2021-04-01
  • 通信作者: 阳东荣

Correlation analysis between S.T.O.N.E. score and stone clearance rate or the complications in renal calculi patients treated with percutaneous nephrolithotomy

Jianfang Zhou1, Cheng Gao1, Dongrong Yang1,()   

  1. 1. Department of Urology, the Second Affiliated Hospital of Soochow University, Suzhou 215004, China
  • Received:2020-03-09 Published:2021-04-01
  • Corresponding author: Dongrong Yang
引用本文:

周剑芳, 高诚, 阳东荣. S.T.O.N.E.评分与肾结石经皮肾镜术后清石率及并发症的相关性分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2021, 15(02): 121-125.

Jianfang Zhou, Cheng Gao, Dongrong Yang. Correlation analysis between S.T.O.N.E. score and stone clearance rate or the complications in renal calculi patients treated with percutaneous nephrolithotomy[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2021, 15(02): 121-125.

目的

探讨S.T.O.N.E.肾结石评分与PCNL治疗肾结石术后清石率及并发症的相关性。

方法

回顾性分析2012年10月至2018年10月我院接受PCNL手术治疗的肾结石患者临床资料。根据术后结石清除状态将患者分为结石清除组与结石残留组,比较两组之间S.T.O.N.E.评分的差异。同时按Clavien-Dindo分级对术后并发症进行分级,比较无并发症及1~2级并发症(非重度并发症组)与3~4级并发症(重度并发症组)之间S.T.O.N.E.评分的差异。

结果

共统计630例患者资料,其中381例纳入最终分析。其中结石完全清除246例,结石有残留135例。结石残留组与结石清除组S.T.O.N.E.评分差异有统计学意义(P<0.001)。381例患者中188例(49.34%)无术后并发症,193例(50.66%)患者术后出现程度不一的并发症。1~2级并发症158例,3~4级并发症35例,非重度并发症组与重度并发症组的S.T.O.N.E.评分,差异有统计学意义(P=0.006)。

结论

S.T.O.N.E.肾结石评分系统能预测肾结石PCNL手术的清除效果,评分高低与并发症程度有相关性。

Objective

To investigate the correlation between S.T.O.N.E. kidney stone score and stone clearance rate or complications after PCNL for renal calculi.

Methods

The clinical data of patients with renal calculi who underwent PCNL surgery from October 2012 to October 2018 in our hospital were retrospectively analyzed. The patients were divided into stone clearance group and non stone clearance group according to postoperative stone clearance status, and the differences in S.T.O.N.E. scores between the two groups were compared. Postoperative complications were also graded according to Clavien-Dindo classification, and the differences in S.T.O.N.E. scores between no complications and grade 1-2 complications (non-severe complication group) and grade 3-4 complications (severe complication group) were compared.

Results

A total of 630 patient data were counted, of which 381 were included in the final analysis. Of these, 246 had complete stone clearance and 135 had residual stones. There was significant difference in S.T.O.N.E. score between the two groups (P>0.001). Of the 381 patients, 188(49.34%) had no postoperative complications, and 193(50.66%) patients had complications of varying degrees after surgery. There were 158 cases of grade 1-2 complications and 35 cases of grade 3-4 complications. There was significant difference in S.T.O.N.E. score between severe complication group and non-severe complication group (P=0.006).

Conclusion

S.T.O.N.E. kidney stone scoring system can predict the removal effect of PCNL for renal calculi, and the score is correlated with the degree of complications.

表1 S.T.O.N.E.肾结石评分细则
表2 Clavien-Dindo分级系统
表3 结石清除组和结石残留组临床资料比较
表4 S.T.O.N.E.评分与结石清除率的Logistic回归分析
表5 无并发症组、轻度并发症组、重度并发症组的比较
表6 S.T.O.N.E.评分与PCNL术后是否出现重度并发症的相关性分析
[1]
Fernstrom I, Johansson B. Percutaneous pyelolithotomy[J]. Scand J Urol Nephrol, 1976, 10(3): 257-259.
[2]
栾光超,王勤章,钱彪, 等. 经皮肾镜术后尿源性脓毒血症相关危险因素的Meta分析[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2019, 13(2): 103-107.
[3]
Wu WJ, Okeke Z. Current clinical scoring systems of percutaneous nephrolithotomy outcomes[J]. Nat Rev Urol, 2017, 14(8): 459-469.
[4]
Zhu ZW, Wang SG, Xi QL, et al. Logistic regression model for predicting stone-free rate after minimally invasive percutaneous nephrolithotomy[J]. Urology, 2011, 78(1): 32-36.
[5]
Mishra S, Sabnis RB, Desai M. Staghorn morphometry: a new tool for clinical classification and prediction model for percutaneous nephrolithotomy monotherapy[J]. J Endourol, 2012, 26(1): 6-14.
[6]
Thomas K, Smith NC, Hegarty N, et al. The Guy's stone score-grading the complexity of percutaneous nephrolithotomy procedures[J]. Urology, 2011, 78(2): 277-281.
[7]
Okhunov Z, Friedlander JI, George AK, et al. S.T.O.N.E. nephrolithometry: novel surgical classification system for kidney calculi[J]. Urology, 2013, 81(6): 1154-1159.
[8]
苑海春,种铁,薛玉泉, 等. S.T.O.N.E.评分系统预测经皮肾镜取石清石率和术后并发症的分析[J]. 微创泌尿外科杂志, 2019, 8(2): 108-113.
[9]
黎灿强,徐乐,邱敏捷, 等. S.T.O.N.E.评分系统与经皮肾镜碎石术后并发症及结石清除状态的关系[J]. 现代泌尿外科杂志, 2015, 20(1): 44-47.
[10]
Clavien PA, Barkun J, Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience[J]. Ann Surg, 2009, 250(2): 187-196.
[11]
周立权,徐广龙,邓耀良, 等. S.T.O.N.E.肾结石评分系统预测PCNL结石清除率及并发症的临床应用价值分析[J]. 临床泌尿外科杂志, 2018, 33(2): 89-92.
[12]
Akhavein A, Henriksen C, Syed J, et al. Prediction of single procedure success rate using S.T.O.N.E. nephrolithometry surgical classification system with strict criteria for surgical outcome[J]. Urology, 2015, 85(1): 69-73.
[13]
郑秀龙,李延江,荆涛, 等. S.T.O.N.E.评分系统与经皮肾镜取石术并发症的相关性研究[J]. 临床泌尿外科杂志, 2018, 33(11): 894-898.
[14]
党博文,米华. 经皮肾镜碎石取石术并发出血的原因及防治[J/CD].中华腔镜泌尿外科杂志(电子版), 2018, 12(3): 214-216.
[15]
项平,诸禹平,朱劲松, 等. Ⅰ期多通道与多期多通道微创经皮肾镜治疗复杂性肾结石疗效比较[J]. 现代泌尿外科杂志, 2010, 15(2): 120-122.
[16]
Tang R, Sawka A, Vaghadia H, et al. SonixGPS - the role of operator experience[J]. Anaesthesia, 2014, 69(9): 1060-1061.
[17]
Du C, Song LM, Wu XY, et al. Suctioning Minimally Invasive Percutaneous Nephrolithotomy with a Patented System Is Effective to Treat Renal Staghorn Calculi: A Prospective Multicenter Study[J]. Urol Int, 2018, 101(2): 143-149.
[18]
Cho SY. Current status of flexible ureteroscopy in urology[J]. Korean J Urol, 2015, 56(10): 680-688.
[1] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[2] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[3] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[7] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[8] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[9] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[10] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[11] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[12] 曹彬, 王强, 卢扬柏, 黄红星, 黄亚强, 龙永富, 钟睿, 李灿永, 罗刚. 单孔经皮肾镜和腹腔镜处理肾囊肿的术式对比研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 566-571.
[13] 石兵, 张智, 陈金海, 唐文. 基于电磁跟踪和手术导航系统的实时超声引导下两种经皮肾盏穿刺方法的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 572-578.
[14] 嵇振岭, 陈杰, 唐健雄. 重视复杂腹壁疝手术并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 601-606.
[15] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
阅读次数
全文


摘要